Economic impact of abrocitinib monotherapy and combination therapy in patients with moderate-to-severe atopic dermatitis: Results from JADE MONO-2 and JADE COMPARE.

ABSTRACT:

SUBMITTER: Gooderham MJ 

PROVIDER: S-EPMC8361901 | biostudies-literature | 2021 Sep

REPOSITORIES: biostudies-literature